Office of Health Data and Research, Mississippi State Department of Health, 570 East Woodrow Wilson Drive, Jackson, MS 39215. Email:
Office of Health Data and Research, Mississippi State Department of Health, Jackson, Mississippi.
Prev Chronic Dis. 2017 Sep 7;14:E77. doi: 10.5888/pcd14.170171.
We used data from the 2013 Mississippi Behavioral Risk Factor Surveillance System to examine aspirin use for the prevention of primary and secondary cardiovascular disease (CVD), based on the 2009 US Preventive Services Task Force (USPSTF) guidelines, among Mississippi men (aged 45-79 y) and women (aged 55-79 y) and to explore differences in aspirin use by sociodemographic characteristics. Among those without CVD, 39.1% of men and 45.9% of women reported taking aspirin, and among those with CVD, 85.9% of men and 85.1% of women reported taking aspirin. Data on preventive use of aspirin by sociodemographic characteristics yielded mixed results.
我们使用了 2013 年密西西比州行为风险因素监测系统的数据，根据 2009 年美国预防服务工作组（USPSTF）的指南，对密西西比州 45-79 岁男性和 55-79 岁女性（年龄）进行了预防原发性和继发性心血管疾病（CVD）的阿司匹林使用情况进行了研究，并探讨了阿司匹林使用情况在社会人口统计学特征方面的差异。在没有 CVD 的人群中，有 39.1%的男性和 45.9%的女性报告服用阿司匹林，而在有 CVD 的人群中，有 85.9%的男性和 85.1%的女性报告服用阿司匹林。关于社会人口统计学特征的阿司匹林预防使用的数据得出了混合的结果。
